1-5 of 5
Zicong Huang
Close
Sort by
Journal Articles

CRM1/XPO1-FOXO1 Pathway Is Associated with Clinical Outcome and Represents a Promising Target in B-Cell Acute Lymphocytic Leukemia

Shiyu Deng, Jiawang Ou, Cai Zihong, Zicong Huang, Jia Li, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 4253.
https://doi.org/10.1182/blood-2023-188459
Published: 2023
Journal Articles

Prognostic Significance of Epigenetic Modifiers Gene Mutations in Adult Acute Lymphoblastic Leukemia at Diagnosis

Jiawang Ou, Xiuli Xu, Zicong Huang, Shiyu Deng, Cai Zihong, Bingqing Tang, Xiaojie Liang, Zhengwei Wu, Yiqian Liu, Lingling Zhou, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 3475.
https://doi.org/10.1182/blood-2022-166404
Published: 2022
Journal Articles

Chemotherapy or Hematopoietic Stem Cell Transplantation in B-Lineage Acute Lymphoblastic Leukemia Patients Based on IKZF1 and MRD Status

Shiyu Deng, Jiawang Ou, Zicong Huang, Cai Zihong, Bingqing Tang, Xiuli Xu, Yiqian Liu, Zhengwei Wu, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 11856.
https://doi.org/10.1182/blood-2022-166780
Published: 2022
Journal Articles

Dynamics of Minimal Residual Disease Defines a Novel Risk-Classification and the Role of Allo-HSCT in Adult Ph-Negative B Cell Acute Lymphoblastic Leukemia

Cai Zihong, Bingqing Tang, Xiuli Xu, Zicong Huang, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 9205–9206.
https://doi.org/10.1182/blood-2022-165201
Published: 2022
Journal Articles

Metabolic Feature Profiling and Metabolic Vulnerability Targeting in B-Cell Lymphoblastic Leukemia

Xiaojie Liang, Bingqing Tang, Cai Zihong, Zicong Huang, Baiwei Luo, Bingyu Lin, Yunong Yang, Qifa Liu, Hongsheng Zhou
Journal: Blood
Blood (2022) 140 (Supplement 1): 6361–6362.
https://doi.org/10.1182/blood-2022-166637
Published: 2022